Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? Gianluca TrifiròSalvatore Crisafullithe Italian Society of Pharmacology Editorial 17 April 2020 Pages: 507 - 509
The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic Rebecca E ChandlerDeirdre McCarthyMira Harrison-Woolrych From the ISoP Open access 07 May 2020 Pages: 511 - 512
Erice Call for Change: Utilising Patient Experiences to Enhance the Quality and Safety of Healthcare Elena RoccaRani Lill Anjum Special Article Open access 15 April 2020 Pages: 513 - 515
Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review Fatema A. AlqenaeDouglas SteinkeRichard N. Keers Systematic Review Open access 03 March 2020 Pages: 517 - 537
Benzodiazepine Use and Risk of Acute Angle-Closure Glaucoma: A Population-Based Case-Crossover Study Woo Jung KimJunqing LiJu-Young Shin Original Research Article 07 February 2020 Pages: 539 - 547
Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies Romain DemaillySylvie EscolanoIsmaïl Ahmed Original Research Article 02 March 2020 Pages: 549 - 559
Fluoroquinolone-Induced Photosensitivity: A Chemical Fragment-Based Approach by a Case/Non-case Study in VigiBase® Yoann ZelmatVanessa RousseauAgnès Sommet Original Research Article 07 March 2020 Pages: 561 - 566
Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use Rebecca N. JeromeMeghan Morrison JolyJill M. Pulley Original Research Article 28 February 2020 Pages: 567 - 582
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi Viviane JusotFrider ChimimbaYolanda Guerra Mendoza Original Research Article Open access 01 April 2020 Pages: 583 - 593
Patterns of Inpatient Antibiotic Use Among Public Hospitals in Hong Kong from 2000 to 2015 Celine S. L. ChuiBenjamin J. CowlingPeng Wu Original Research Article 12 March 2020 Pages: 595 - 606
A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS) Kate E. ReesTe-yuan ChyouPrasad S. Nishtala Research Letter 04 April 2020 Pages: 607 - 609